Norrie Russell has joined Invitrogen as vice president and general manager of its functional genomics strategic business unit, the company said last week. Most recently, he was president and CEO of Aviva Biosciences. Prior to that, he was president and CEO of Lynx Therapeutics. Russell holds a PhD in physiology from Glasgow University in Scotland.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.